0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global In Vitro Diagnostic Kit Raw Materials Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-8H13394
Home | Market Reports | Health| Nursing
Global In Vitro Diagnostic Kit Raw Materials Market Research Report 2023
BUY CHAPTERS

Global In Vitro Diagnostic Kit Raw Materials Market Research Report 2025

Code: QYRE-Auto-8H13394
Report
March 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

In Vitro Diagnostic Kit Raw Materials Market Size

The global market for In Vitro Diagnostic Kit Raw Materials was valued at US$ 14040 million in the year 2024 and is projected to reach a revised size of US$ 20590 million by 2031, growing at a CAGR of 5.7% during the forecast period.

In Vitro Diagnostic Kit Raw Materials Market

In Vitro Diagnostic Kit Raw Materials Market

The core raw materials of in vitro diagnostic (IVD) reagents / kits include antibodies, antigens, enzymes, etc., which are important determinants of the quality and effectiveness of the reagents / kits. Although there are a variety of commercially available products in raw material market, it is difficult to meet all the needs from IVD reagent manufacturers.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for In Vitro Diagnostic Kit Raw Materials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Diagnostic Kit Raw Materials.
The In Vitro Diagnostic Kit Raw Materials market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In Vitro Diagnostic Kit Raw Materials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Diagnostic Kit Raw Materials companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of In Vitro Diagnostic Kit Raw Materials Market Report

Report Metric Details
Report Name In Vitro Diagnostic Kit Raw Materials Market
Accounted market size in year US$ 14040 million
Forecasted market size in 2031 US$ 20590 million
CAGR 5.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher, Hytest, BBI Solution, Meridian, Merck, Roche, TOYOBO, Sekisui Diagnostic, Meikang Bio, Anke Bio, Human Wellbeing Medicine, Norwegian, GenScript, Feipeng Bio, Bumrungrad Bio, Apis Bio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of In Vitro Diagnostic Kit Raw Materials company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is In Vitro Diagnostic Kit Raw Materials Market growing?

Ans: The In Vitro Diagnostic Kit Raw Materials Market witnessing a CAGR of 5.7% during the forecast period 2025-2031.

What is the In Vitro Diagnostic Kit Raw Materials Market size in 2031?

Ans: The In Vitro Diagnostic Kit Raw Materials Market size in 2031 will be US$ 20590 million.

Who are the main players in the In Vitro Diagnostic Kit Raw Materials Market report?

Ans: The main players in the In Vitro Diagnostic Kit Raw Materials Market are Thermo Fisher, Hytest, BBI Solution, Meridian, Merck, Roche, TOYOBO, Sekisui Diagnostic, Meikang Bio, Anke Bio, Human Wellbeing Medicine, Norwegian, GenScript, Feipeng Bio, Bumrungrad Bio, Apis Bio

What are the Application segmentation covered in the In Vitro Diagnostic Kit Raw Materials Market report?

Ans: The Applications covered in the In Vitro Diagnostic Kit Raw Materials Market report are Immunodiagnostic Reagents, Chemical Diagnostic Reagents, Molecular Diagnostic Reagents, Point-of-care Reagents, Other

What are the Type segmentation covered in the In Vitro Diagnostic Kit Raw Materials Market report?

Ans: The Types covered in the In Vitro Diagnostic Kit Raw Materials Market report are Antigens and Antibodies, Enzymes and Coenzymes, Other

Recommended Reports

Diagnostic Kits & Reagents

Raw Materials & Consumables

Testing Market Expansion

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Diagnostic Kit Raw Materials Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antigens and Antibodies
1.2.3 Enzymes and Coenzymes
1.2.4 Other
1.3 Market by Application
1.3.1 Global In Vitro Diagnostic Kit Raw Materials Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Immunodiagnostic Reagents
1.3.3 Chemical Diagnostic Reagents
1.3.4 Molecular Diagnostic Reagents
1.3.5 Point-of-care Reagents
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Diagnostic Kit Raw Materials Market Perspective (2020-2031)
2.2 Global In Vitro Diagnostic Kit Raw Materials Growth Trends by Region
2.2.1 Global In Vitro Diagnostic Kit Raw Materials Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 In Vitro Diagnostic Kit Raw Materials Historic Market Size by Region (2020-2025)
2.2.3 In Vitro Diagnostic Kit Raw Materials Forecasted Market Size by Region (2026-2031)
2.3 In Vitro Diagnostic Kit Raw Materials Market Dynamics
2.3.1 In Vitro Diagnostic Kit Raw Materials Industry Trends
2.3.2 In Vitro Diagnostic Kit Raw Materials Market Drivers
2.3.3 In Vitro Diagnostic Kit Raw Materials Market Challenges
2.3.4 In Vitro Diagnostic Kit Raw Materials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Diagnostic Kit Raw Materials Players by Revenue
3.1.1 Global Top In Vitro Diagnostic Kit Raw Materials Players by Revenue (2020-2025)
3.1.2 Global In Vitro Diagnostic Kit Raw Materials Revenue Market Share by Players (2020-2025)
3.2 Global In Vitro Diagnostic Kit Raw Materials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by In Vitro Diagnostic Kit Raw Materials Revenue
3.4 Global In Vitro Diagnostic Kit Raw Materials Market Concentration Ratio
3.4.1 Global In Vitro Diagnostic Kit Raw Materials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Diagnostic Kit Raw Materials Revenue in 2024
3.5 Global Key Players of In Vitro Diagnostic Kit Raw Materials Head office and Area Served
3.6 Global Key Players of In Vitro Diagnostic Kit Raw Materials, Product and Application
3.7 Global Key Players of In Vitro Diagnostic Kit Raw Materials, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Diagnostic Kit Raw Materials Breakdown Data by Type
4.1 Global In Vitro Diagnostic Kit Raw Materials Historic Market Size by Type (2020-2025)
4.2 Global In Vitro Diagnostic Kit Raw Materials Forecasted Market Size by Type (2026-2031)
5 In Vitro Diagnostic Kit Raw Materials Breakdown Data by Application
5.1 Global In Vitro Diagnostic Kit Raw Materials Historic Market Size by Application (2020-2025)
5.2 Global In Vitro Diagnostic Kit Raw Materials Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America In Vitro Diagnostic Kit Raw Materials Market Size (2020-2031)
6.2 North America In Vitro Diagnostic Kit Raw Materials Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America In Vitro Diagnostic Kit Raw Materials Market Size by Country (2020-2025)
6.4 North America In Vitro Diagnostic Kit Raw Materials Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro Diagnostic Kit Raw Materials Market Size (2020-2031)
7.2 Europe In Vitro Diagnostic Kit Raw Materials Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe In Vitro Diagnostic Kit Raw Materials Market Size by Country (2020-2025)
7.4 Europe In Vitro Diagnostic Kit Raw Materials Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Diagnostic Kit Raw Materials Market Size (2020-2031)
8.2 Asia-Pacific In Vitro Diagnostic Kit Raw Materials Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific In Vitro Diagnostic Kit Raw Materials Market Size by Region (2020-2025)
8.4 Asia-Pacific In Vitro Diagnostic Kit Raw Materials Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vitro Diagnostic Kit Raw Materials Market Size (2020-2031)
9.2 Latin America In Vitro Diagnostic Kit Raw Materials Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America In Vitro Diagnostic Kit Raw Materials Market Size by Country (2020-2025)
9.4 Latin America In Vitro Diagnostic Kit Raw Materials Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Diagnostic Kit Raw Materials Market Size (2020-2031)
10.2 Middle East & Africa In Vitro Diagnostic Kit Raw Materials Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa In Vitro Diagnostic Kit Raw Materials Market Size by Country (2020-2025)
10.4 Middle East & Africa In Vitro Diagnostic Kit Raw Materials Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Details
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher In Vitro Diagnostic Kit Raw Materials Introduction
11.1.4 Thermo Fisher Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
11.1.5 Thermo Fisher Recent Development
11.2 Hytest
11.2.1 Hytest Company Details
11.2.2 Hytest Business Overview
11.2.3 Hytest In Vitro Diagnostic Kit Raw Materials Introduction
11.2.4 Hytest Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
11.2.5 Hytest Recent Development
11.3 BBI Solution
11.3.1 BBI Solution Company Details
11.3.2 BBI Solution Business Overview
11.3.3 BBI Solution In Vitro Diagnostic Kit Raw Materials Introduction
11.3.4 BBI Solution Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
11.3.5 BBI Solution Recent Development
11.4 Meridian
11.4.1 Meridian Company Details
11.4.2 Meridian Business Overview
11.4.3 Meridian In Vitro Diagnostic Kit Raw Materials Introduction
11.4.4 Meridian Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
11.4.5 Meridian Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck In Vitro Diagnostic Kit Raw Materials Introduction
11.5.4 Merck Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
11.5.5 Merck Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche In Vitro Diagnostic Kit Raw Materials Introduction
11.6.4 Roche Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
11.6.5 Roche Recent Development
11.7 TOYOBO
11.7.1 TOYOBO Company Details
11.7.2 TOYOBO Business Overview
11.7.3 TOYOBO In Vitro Diagnostic Kit Raw Materials Introduction
11.7.4 TOYOBO Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
11.7.5 TOYOBO Recent Development
11.8 Sekisui Diagnostic
11.8.1 Sekisui Diagnostic Company Details
11.8.2 Sekisui Diagnostic Business Overview
11.8.3 Sekisui Diagnostic In Vitro Diagnostic Kit Raw Materials Introduction
11.8.4 Sekisui Diagnostic Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
11.8.5 Sekisui Diagnostic Recent Development
11.9 Meikang Bio
11.9.1 Meikang Bio Company Details
11.9.2 Meikang Bio Business Overview
11.9.3 Meikang Bio In Vitro Diagnostic Kit Raw Materials Introduction
11.9.4 Meikang Bio Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
11.9.5 Meikang Bio Recent Development
11.10 Anke Bio
11.10.1 Anke Bio Company Details
11.10.2 Anke Bio Business Overview
11.10.3 Anke Bio In Vitro Diagnostic Kit Raw Materials Introduction
11.10.4 Anke Bio Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
11.10.5 Anke Bio Recent Development
11.11 Human Wellbeing Medicine
11.11.1 Human Wellbeing Medicine Company Details
11.11.2 Human Wellbeing Medicine Business Overview
11.11.3 Human Wellbeing Medicine In Vitro Diagnostic Kit Raw Materials Introduction
11.11.4 Human Wellbeing Medicine Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
11.11.5 Human Wellbeing Medicine Recent Development
11.12 Norwegian
11.12.1 Norwegian Company Details
11.12.2 Norwegian Business Overview
11.12.3 Norwegian In Vitro Diagnostic Kit Raw Materials Introduction
11.12.4 Norwegian Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
11.12.5 Norwegian Recent Development
11.13 GenScript
11.13.1 GenScript Company Details
11.13.2 GenScript Business Overview
11.13.3 GenScript In Vitro Diagnostic Kit Raw Materials Introduction
11.13.4 GenScript Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
11.13.5 GenScript Recent Development
11.14 Feipeng Bio
11.14.1 Feipeng Bio Company Details
11.14.2 Feipeng Bio Business Overview
11.14.3 Feipeng Bio In Vitro Diagnostic Kit Raw Materials Introduction
11.14.4 Feipeng Bio Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
11.14.5 Feipeng Bio Recent Development
11.15 Bumrungrad Bio
11.15.1 Bumrungrad Bio Company Details
11.15.2 Bumrungrad Bio Business Overview
11.15.3 Bumrungrad Bio In Vitro Diagnostic Kit Raw Materials Introduction
11.15.4 Bumrungrad Bio Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
11.15.5 Bumrungrad Bio Recent Development
11.16 Apis Bio
11.16.1 Apis Bio Company Details
11.16.2 Apis Bio Business Overview
11.16.3 Apis Bio In Vitro Diagnostic Kit Raw Materials Introduction
11.16.4 Apis Bio Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
11.16.5 Apis Bio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global In Vitro Diagnostic Kit Raw Materials Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Antigens and Antibodies
 Table 3. Key Players of Enzymes and Coenzymes
 Table 4. Key Players of Other
 Table 5. Global In Vitro Diagnostic Kit Raw Materials Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global In Vitro Diagnostic Kit Raw Materials Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global In Vitro Diagnostic Kit Raw Materials Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global In Vitro Diagnostic Kit Raw Materials Market Share by Region (2020-2025)
 Table 9. Global In Vitro Diagnostic Kit Raw Materials Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global In Vitro Diagnostic Kit Raw Materials Market Share by Region (2026-2031)
 Table 11. In Vitro Diagnostic Kit Raw Materials Market Trends
 Table 12. In Vitro Diagnostic Kit Raw Materials Market Drivers
 Table 13. In Vitro Diagnostic Kit Raw Materials Market Challenges
 Table 14. In Vitro Diagnostic Kit Raw Materials Market Restraints
 Table 15. Global In Vitro Diagnostic Kit Raw Materials Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global In Vitro Diagnostic Kit Raw Materials Market Share by Players (2020-2025)
 Table 17. Global Top In Vitro Diagnostic Kit Raw Materials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Diagnostic Kit Raw Materials as of 2024)
 Table 18. Ranking of Global Top In Vitro Diagnostic Kit Raw Materials Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by In Vitro Diagnostic Kit Raw Materials Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of In Vitro Diagnostic Kit Raw Materials, Headquarters and Area Served
 Table 21. Global Key Players of In Vitro Diagnostic Kit Raw Materials, Product and Application
 Table 22. Global Key Players of In Vitro Diagnostic Kit Raw Materials, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global In Vitro Diagnostic Kit Raw Materials Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global In Vitro Diagnostic Kit Raw Materials Revenue Market Share by Type (2020-2025)
 Table 26. Global In Vitro Diagnostic Kit Raw Materials Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global In Vitro Diagnostic Kit Raw Materials Revenue Market Share by Type (2026-2031)
 Table 28. Global In Vitro Diagnostic Kit Raw Materials Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global In Vitro Diagnostic Kit Raw Materials Revenue Market Share by Application (2020-2025)
 Table 30. Global In Vitro Diagnostic Kit Raw Materials Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global In Vitro Diagnostic Kit Raw Materials Revenue Market Share by Application (2026-2031)
 Table 32. North America In Vitro Diagnostic Kit Raw Materials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America In Vitro Diagnostic Kit Raw Materials Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America In Vitro Diagnostic Kit Raw Materials Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe In Vitro Diagnostic Kit Raw Materials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe In Vitro Diagnostic Kit Raw Materials Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe In Vitro Diagnostic Kit Raw Materials Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific In Vitro Diagnostic Kit Raw Materials Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific In Vitro Diagnostic Kit Raw Materials Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific In Vitro Diagnostic Kit Raw Materials Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America In Vitro Diagnostic Kit Raw Materials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America In Vitro Diagnostic Kit Raw Materials Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America In Vitro Diagnostic Kit Raw Materials Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa In Vitro Diagnostic Kit Raw Materials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa In Vitro Diagnostic Kit Raw Materials Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa In Vitro Diagnostic Kit Raw Materials Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Thermo Fisher Company Details
 Table 48. Thermo Fisher Business Overview
 Table 49. Thermo Fisher In Vitro Diagnostic Kit Raw Materials Product
 Table 50. Thermo Fisher Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025) & (US$ Million)
 Table 51. Thermo Fisher Recent Development
 Table 52. Hytest Company Details
 Table 53. Hytest Business Overview
 Table 54. Hytest In Vitro Diagnostic Kit Raw Materials Product
 Table 55. Hytest Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025) & (US$ Million)
 Table 56. Hytest Recent Development
 Table 57. BBI Solution Company Details
 Table 58. BBI Solution Business Overview
 Table 59. BBI Solution In Vitro Diagnostic Kit Raw Materials Product
 Table 60. BBI Solution Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025) & (US$ Million)
 Table 61. BBI Solution Recent Development
 Table 62. Meridian Company Details
 Table 63. Meridian Business Overview
 Table 64. Meridian In Vitro Diagnostic Kit Raw Materials Product
 Table 65. Meridian Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025) & (US$ Million)
 Table 66. Meridian Recent Development
 Table 67. Merck Company Details
 Table 68. Merck Business Overview
 Table 69. Merck In Vitro Diagnostic Kit Raw Materials Product
 Table 70. Merck Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025) & (US$ Million)
 Table 71. Merck Recent Development
 Table 72. Roche Company Details
 Table 73. Roche Business Overview
 Table 74. Roche In Vitro Diagnostic Kit Raw Materials Product
 Table 75. Roche Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025) & (US$ Million)
 Table 76. Roche Recent Development
 Table 77. TOYOBO Company Details
 Table 78. TOYOBO Business Overview
 Table 79. TOYOBO In Vitro Diagnostic Kit Raw Materials Product
 Table 80. TOYOBO Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025) & (US$ Million)
 Table 81. TOYOBO Recent Development
 Table 82. Sekisui Diagnostic Company Details
 Table 83. Sekisui Diagnostic Business Overview
 Table 84. Sekisui Diagnostic In Vitro Diagnostic Kit Raw Materials Product
 Table 85. Sekisui Diagnostic Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025) & (US$ Million)
 Table 86. Sekisui Diagnostic Recent Development
 Table 87. Meikang Bio Company Details
 Table 88. Meikang Bio Business Overview
 Table 89. Meikang Bio In Vitro Diagnostic Kit Raw Materials Product
 Table 90. Meikang Bio Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025) & (US$ Million)
 Table 91. Meikang Bio Recent Development
 Table 92. Anke Bio Company Details
 Table 93. Anke Bio Business Overview
 Table 94. Anke Bio In Vitro Diagnostic Kit Raw Materials Product
 Table 95. Anke Bio Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025) & (US$ Million)
 Table 96. Anke Bio Recent Development
 Table 97. Human Wellbeing Medicine Company Details
 Table 98. Human Wellbeing Medicine Business Overview
 Table 99. Human Wellbeing Medicine In Vitro Diagnostic Kit Raw Materials Product
 Table 100. Human Wellbeing Medicine Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025) & (US$ Million)
 Table 101. Human Wellbeing Medicine Recent Development
 Table 102. Norwegian Company Details
 Table 103. Norwegian Business Overview
 Table 104. Norwegian In Vitro Diagnostic Kit Raw Materials Product
 Table 105. Norwegian Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025) & (US$ Million)
 Table 106. Norwegian Recent Development
 Table 107. GenScript Company Details
 Table 108. GenScript Business Overview
 Table 109. GenScript In Vitro Diagnostic Kit Raw Materials Product
 Table 110. GenScript Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025) & (US$ Million)
 Table 111. GenScript Recent Development
 Table 112. Feipeng Bio Company Details
 Table 113. Feipeng Bio Business Overview
 Table 114. Feipeng Bio In Vitro Diagnostic Kit Raw Materials Product
 Table 115. Feipeng Bio Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025) & (US$ Million)
 Table 116. Feipeng Bio Recent Development
 Table 117. Bumrungrad Bio Company Details
 Table 118. Bumrungrad Bio Business Overview
 Table 119. Bumrungrad Bio In Vitro Diagnostic Kit Raw Materials Product
 Table 120. Bumrungrad Bio Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025) & (US$ Million)
 Table 121. Bumrungrad Bio Recent Development
 Table 122. Apis Bio Company Details
 Table 123. Apis Bio Business Overview
 Table 124. Apis Bio In Vitro Diagnostic Kit Raw Materials Product
 Table 125. Apis Bio Revenue in In Vitro Diagnostic Kit Raw Materials Business (2020-2025) & (US$ Million)
 Table 126. Apis Bio Recent Development
 Table 127. Research Programs/Design for This Report
 Table 128. Key Data Information from Secondary Sources
 Table 129. Key Data Information from Primary Sources
 Table 130. Authors List of This Report


List of Figures
 Figure 1. In Vitro Diagnostic Kit Raw Materials Picture
 Figure 2. Global In Vitro Diagnostic Kit Raw Materials Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global In Vitro Diagnostic Kit Raw Materials Market Share by Type: 2024 VS 2031
 Figure 4. Antigens and Antibodies Features
 Figure 5. Enzymes and Coenzymes Features
 Figure 6. Other Features
 Figure 7. Global In Vitro Diagnostic Kit Raw Materials Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global In Vitro Diagnostic Kit Raw Materials Market Share by Application: 2024 VS 2031
 Figure 9. Immunodiagnostic Reagents Case Studies
 Figure 10. Chemical Diagnostic Reagents Case Studies
 Figure 11. Molecular Diagnostic Reagents Case Studies
 Figure 12. Point-of-care Reagents Case Studies
 Figure 13. Other Case Studies
 Figure 14. In Vitro Diagnostic Kit Raw Materials Report Years Considered
 Figure 15. Global In Vitro Diagnostic Kit Raw Materials Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global In Vitro Diagnostic Kit Raw Materials Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global In Vitro Diagnostic Kit Raw Materials Market Share by Region: 2024 VS 2031
 Figure 18. Global In Vitro Diagnostic Kit Raw Materials Market Share by Players in 2024
 Figure 19. Global Top In Vitro Diagnostic Kit Raw Materials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Diagnostic Kit Raw Materials as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by In Vitro Diagnostic Kit Raw Materials Revenue in 2024
 Figure 21. North America In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America In Vitro Diagnostic Kit Raw Materials Market Share by Country (2020-2031)
 Figure 23. United States In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe In Vitro Diagnostic Kit Raw Materials Market Share by Country (2020-2031)
 Figure 27. Germany In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific In Vitro Diagnostic Kit Raw Materials Market Share by Region (2020-2031)
 Figure 35. China In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America In Vitro Diagnostic Kit Raw Materials Market Share by Country (2020-2031)
 Figure 43. Mexico In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa In Vitro Diagnostic Kit Raw Materials Market Share by Country (2020-2031)
 Figure 47. Turkey In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE In Vitro Diagnostic Kit Raw Materials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Thermo Fisher Revenue Growth Rate in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
 Figure 51. Hytest Revenue Growth Rate in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
 Figure 52. BBI Solution Revenue Growth Rate in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
 Figure 53. Meridian Revenue Growth Rate in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
 Figure 54. Merck Revenue Growth Rate in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
 Figure 55. Roche Revenue Growth Rate in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
 Figure 56. TOYOBO Revenue Growth Rate in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
 Figure 57. Sekisui Diagnostic Revenue Growth Rate in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
 Figure 58. Meikang Bio Revenue Growth Rate in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
 Figure 59. Anke Bio Revenue Growth Rate in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
 Figure 60. Human Wellbeing Medicine Revenue Growth Rate in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
 Figure 61. Norwegian Revenue Growth Rate in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
 Figure 62. GenScript Revenue Growth Rate in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
 Figure 63. Feipeng Bio Revenue Growth Rate in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
 Figure 64. Bumrungrad Bio Revenue Growth Rate in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
 Figure 65. Apis Bio Revenue Growth Rate in In Vitro Diagnostic Kit Raw Materials Business (2020-2025)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS